{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:52:46Z","timestamp":1762869166613,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.radonc.2023.109855","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T06:22:40Z","timestamp":1692339760000},"page":"109855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The prognosis of patients with prostate cancer receiving permanent seed implantation stratified by prostate volume: Should we be reluctant to treat with brachytherapy because of a very small prostate (&lt;15\u00a0cc)?"],"prefix":"10.1016","volume":"188","author":[{"given":"Koji","family":"Masui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihisa","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Higashide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109855_b0005","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1200\/JCO.2005.05.525","article-title":"Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study","volume":"23","author":"Freedland","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109855_b0010","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.ejca.2007.09.022","article-title":"Prostate volume and adverse prostate cancer features: fact not artifact","volume":"43","author":"Briganti","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109855_b0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.juro.2010.04.082","article-title":"Smaller prostate size predicts high grade prostate cancer at final pathology","volume":"184","author":"Newton","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2023.109855_b0020","doi-asserted-by":"crossref","unstructured":"Jayachandran J, Ba\u00f1ez LL, Levy DE, et al. Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database. J Urol. 2008;179:1791-1796; discussion 1796.","DOI":"10.1016\/j.juro.2008.01.043"},{"key":"10.1016\/j.radonc.2023.109855_b0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3346\/jkms.2011.26.6.807","article-title":"Prostate volume has prognostic value only in pathologic T2 radical prostatectomy specimens","volume":"26","author":"Cho","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.radonc.2023.109855_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4111\/kju.2012.53.7.463","article-title":"Impact of prostate size on pathologic outcomes and prognosis after radical prostatectomy","volume":"53","author":"Min","year":"2012","journal-title":"Korean J Urol"},{"key":"10.1016\/j.radonc.2023.109855_b0035","first-page":"3613","article-title":"Ethnicity and migration as determinants of human prostate size","volume":"84","author":"Jin","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.radonc.2023.109855_b0040","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0022-5347(01)66256-6","article-title":"Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries","volume":"155","author":"Masumori","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2023.109855_b0045","doi-asserted-by":"crossref","first-page":"e104917","DOI":"10.1371\/journal.pone.0104917","article-title":"Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting","volume":"9","author":"Lim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2023.109855_b0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10147-014-0704-4","article-title":"Nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)","volume":"20","author":"Saito","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109855_b0055","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s10147-018-1309-0","article-title":"Nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS): first analysis on survival","volume":"23","author":"Ito","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109855_b0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","article-title":"Biologically effective dose values for prostate brachytherapy: effects on PSA failure and post-treatment biopsy results","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0070","unstructured":"National Cancer Institute Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events version 3.0. NCI CTEP Website. Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm."},{"key":"10.1016\/j.radonc.2023.109855_b0075","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ijrobp.2010.01.023","article-title":"Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size","volume":"79","author":"Nguyen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2011.11.068","article-title":"Prognostic importance of small prostate size in men receiving definitive prostate brachytherapy","volume":"84","author":"Taira","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brachy.2009.07.009","article-title":"The dosimetric quality of brachytherapy implants in patients with small prostate volume depends on the experience of the brachytherapy team","volume":"9","author":"Liu","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109855_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brachy.2012.07.001","article-title":"Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community database","volume":"12","author":"Taira","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2023.109855_b0095","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.ijrobp.2009.04.014","article-title":"Permanent prostate brachytherapy in prostate glands <20 cm(3)","volume":"76","author":"Mayadev","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.ju.0000145827.20277.e9","article-title":"Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy","volume":"173","author":"Lehrer","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2023.109855_b0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-5347(05)67998-0","article-title":"The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy","volume":"163","author":"Sebo","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2023.109855_b0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0360-3016(00)01423-1","article-title":"The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer","volume":"49","author":"D'Amico","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0115","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2004.01.164","article-title":"Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease","volume":"22","author":"D'Amico","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109855_b0120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0360-3016(01)02670-0","article-title":"Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.urology.2005.08.047","article-title":"Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer","volume":"67","author":"Rossi","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2023.109855_b0130","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.ijrobp.2011.01.007","article-title":"The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy","volume":"81","author":"Qian","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0135","doi-asserted-by":"crossref","first-page":"735.e9","DOI":"10.1016\/j.urolonc.2020.05.023","article-title":"Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer","volume":"38","author":"Yang","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.radonc.2023.109855_b0140","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.01.005","article-title":"Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy","volume":"79","author":"Taira","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/jcb.2016.58080","article-title":"Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer","volume":"8","author":"Muralidhar","year":"2016","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.radonc.2023.109855_b0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109855_b0155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9\u201310 prostate cancer","volume":"319","author":"Kishan","year":"2018","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2023.109855_b0160","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1038\/s41598-018-28730-1","article-title":"Comparison of image-guided intensity-modulated radiotherapy and low-dose rate brachytherapy with or without external beam radiotherapy in patients with localized prostate cancer","volume":"8","author":"Tsubokura","year":"2018","journal-title":"Sci Rep"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023897493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023897493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:33Z","timestamp":1759123593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023897493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":32,"alternative-id":["S0167814023897493"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109855","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognosis of patients with prostate cancer receiving permanent seed implantation stratified by prostate volume: Should we be reluctant to treat with brachytherapy because of a very small prostate (<15\u00a0cc)?","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109855"}}